Investor Relations News Releases

Revenue was $478.0 million, a 7.9% increase over the prior year Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 Net loss was $102.4 million, inclusive of a $105.1 million non-cash goodwill impairment, compared to net income of $24.3 million in the comparable prior year period

ATLANTA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 9, 2023, to be followed by a conference call at 10:00 a.m.

Revenue was $471.9 million, a 6.5% increase over the prior year Gross margin increased 7.0% to $155.3 million, compared to Q2 2022 Net income was $25.6 million, compared to net loss of $473.9 million in the comparable prior year period Adjusted EBITDA was $35.8 million, a sequential increase of

ATLANTA, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH), a leading provider of care in the home to pediatric, adults, and geriatric patients, announced that it has amended its securitization facility to extend its maturity to July 31, 2026.

ATLANTA, July 20, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 10, 2023, to be followed by a conference call at 10:00 a.m.

ATLANTA, June 15, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that David Afshar has resigned from his position as Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer effective July 7, 2023, to pursue other

Revenue increased 3.5% to $466.4 million, compared to Q1 2022 Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 Net loss was $32.0 million, compared to net income of $25.3 million in Q1 2022 Adjusted EBITDA decreased 25.0% to $28.5 million, compared to Q1 2022 Affirms previously

ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 11, 2023, to be followed by a conference call at 10:00 a.m.

Revenue increased 9.0% to $451.1 million, compared to Q4 2021 Gross margin increased 3.5% to $128.8 million, compared to Q4 2021 Net loss was $237.8 million, compared to net loss of $126.2 million in Q4 2021 Adjusted EBITDA decreased 35% to $29.7 million, compared to Q4 2021 ATLANTA, March 16, 2023

ATLANTA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 16, 2023, to be followed by a conference call at 10 a.m.